The complex syndrome of functional neurological disorder

Abstract Background Patients with functional neurological disorders (FND) often present with multiple motor, sensory, psychological and cognitive symptoms. In order to explore the relationship between these common symptoms, we performed a detailed clinical assessment of motor, non-motor symptoms, health-related quality of life (HRQoL) and disability in a large cohort of patients with motor FND. To understand the clinical heterogeneity, cluster analysis was used to search for subgroups within the cohort. Methods One hundred fifty-two patients with a clinically established diagnosis of motor FND were assessed for motor symptom severity using the Simplified Functional Movement Disorder Rating Scale (S-FMDRS), the number of different motor phenotypes (i.e. tremor, dystonia, gait disorder, myoclonus, and weakness), gait severity and postural instability. All patients then evaluated each motor symptom type severity on a Likert scale and completed questionnaires for depression, anxiety, pain, fatigue, cognitive complaints and HRQoL. Results Significant correlations were found among the self-reported and all objective motor symptoms severity measures. All self-reported measures including HRQoL correlated strongly with each other. S-FMDRS weakly correlated with HRQoL. Hierarchical cluster analysis supplemented with gap statistics revealed a homogenous patient sample which could not be separated into subgroups. Conclusions We interpret the lack of evidence of clusters along with a high degree of correlation between all self-reported and objective measures of motor or non-motor symptoms and HRQoL within current neurobiological models as evidence to support a unified pathophysiology of ‘functional’ symptoms. Our results support the unification of functional and somatic syndromes in classification schemes and for future mechanistic and therapeutic research.

[1]  M. Edwards,et al.  Reduced drift rate: a biomarker of impaired information processing in functional movement disorders. , 2019, Brain : a journal of neurology.

[2]  J. Rosmalen,et al.  Shared demographics and comorbidities in different functional motor disorders. , 2019, Parkinsonism & related disorders.

[3]  A. Ludolph,et al.  Patient-Reported Prevalence of Non-motor Symptoms Is Low in Adult Patients Suffering From 5q Spinal Muscular Atrophy , 2019, Front. Neurol..

[4]  J. Marsden,et al.  Physio4FMD: protocol for a multicentre randomised controlled trial of specialist physiotherapy for functional motor disorder , 2019, BMC Neurology.

[5]  M. Hallett,et al.  Pathogenesis and pathophysiology of functional (psychogenic) movement disorders , 2019, Neurobiology of Disease.

[6]  B. Seymour Pain: A Precision Signal for Reinforcement Learning and Control , 2019, Neuron.

[7]  Sylvie Ratté,et al.  Cluster Analysis of Obesity Disease Based on Comorbidities Extracted from Clinical Notes , 2019, Journal of Medical Systems.

[8]  M. Edwards,et al.  The impact of non-motor symptoms on the health-related quality of life in patients with functional movement disorders. , 2018, Journal of psychosomatic research.

[9]  K. LaFaver,et al.  Motor Retraining (MoRe) for Functional Movement Disorders: Outcomes From a 1‐Week Multidisciplinary Rehabilitation Program , 2018, PM & R : the journal of injury, function, and rehabilitation.

[10]  Mark Hallett,et al.  Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders , 2018, JAMA neurology.

[11]  B. Engelen,et al.  Fatigue, not self-rated motor symptom severity, affects quality of life in functional motor disorders , 2018, Journal of Neurology.

[12]  M. Edwards,et al.  A unifying theory for cognitive abnormalities in functional neurological disorders, fibromyalgia and chronic fatigue syndrome: systematic review , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[13]  A. David,et al.  Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. , 2018, The lancet. Psychiatry.

[14]  Hea Ree Park,et al.  Characteristic Motor and Nonmotor Symptoms Related to Quality of Life in Drug-Naïve Patients with Late-Onset Parkinson Disease , 2018, Neurodegenerative Diseases.

[15]  M. Tijssen,et al.  The presence of depression and anxiety do not distinguish between functional jerks and cortical myoclonus. , 2017, Parkinsonism & related disorders.

[16]  C. Bielza,et al.  Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms , 2017, Front. Aging Neurosci..

[17]  M. Vidailhet,et al.  Impact of Transcranial Magnetic Stimulation on Functional Movement Disorders: Cortical Modulation or a Behavioral Effect? , 2017, Front. Neurol..

[18]  M. Edwards,et al.  A Simplified Version of the Psychogenic Movement Disorders Rating Scale: The Simplified Functional Movement Disorders Rating Scale (S‐FMDRS) , 2017, Movement disorders clinical practice.

[19]  Richard J. Brown,et al.  Symptoms and the body: Taking the inferential leap , 2017, Neuroscience & Biobehavioral Reviews.

[20]  Claudia Beleites,et al.  Interactive Dendrograms: The R Packages idendro and idendr0 , 2017 .

[21]  S.H. Kim,et al.  Identifying fibromyalgia subgroups using cluster analysis: Relationships with clinical variables , 2017, European journal of pain.

[22]  L. F. Barrett,et al.  An active inference theory of allostasis and interoception in depression , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.

[23]  Anna Thorwart,et al.  Why Harmless Sensations Might Hurt in Individuals with Chronic Pain: About Heightened Prediction and Perception of Pain in the Mind , 2016, Front. Psychol..

[24]  Joseph E LeDoux,et al.  Using Neuroscience to Help Understand Fear and Anxiety: A Two-System Framework. , 2016, The American journal of psychiatry.

[25]  K. Chaudhuri,et al.  Non-Motor Symptoms in Patients Suffering from Motor Neuron Diseases , 2016, Front. Neurol..

[26]  G. Prado,et al.  Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis , 2015, Arquivos de Neuro-Psiquiatria.

[27]  R. Camicioli,et al.  Parkinson Disease: The Relationship Between Non-motor Symptoms and Motor Phenotype , 2015, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[28]  S. Park,et al.  Patterns of Motor and Non-Motor Features in Medication-Naïve Parkinsonism , 2015, Neuroepidemiology.

[29]  A. Lang,et al.  Phenotype-Specific Diagnosis of Functional (Psychogenic) Movement Disorders , 2015, Current Neurology and Neuroscience Reports.

[30]  J. Jankovic,et al.  Psychogenic movement disorders. , 2015, Neurologic clinics.

[31]  A. David,et al.  Physiotherapy for functional motor disorders: a consensus recommendation , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[32]  Young Eun Kim,et al.  Identifying the Clusters within Nonmotor Manifestations in Early Parkinson's Disease by Using Unsupervised Cluster Analysis , 2014, PloS one.

[33]  M. Edwards,et al.  The prognosis of functional (psychogenic) motor symptoms: a systematic review , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[34]  Kristen A. Lindquist,et al.  A functional architecture of the human brain: emerging insights from the science of emotion , 2012, Trends in Cognitive Sciences.

[35]  A. Pisani,et al.  The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life , 2012, Journal of Neurology.

[36]  Karl J. Friston,et al.  A Bayesian account of ‘hysteria’ , 2012, Brain : a journal of neurology.

[37]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[38]  K. Chaudhuri,et al.  The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[39]  H. Chiu,et al.  Psychosocial aspects in myasthenic patients treated by plasmapheresis , 2011, Journal of Neurology.

[40]  C. Warlow,et al.  Who is referred to neurology clinics?—The diagnoses made in 3781 new patients , 2010, Clinical Neurology and Neurosurgery.

[41]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[42]  R. D. de Haan,et al.  Determinants of disability and quality of life in mild to moderate Parkinson disease , 2008, Neurology.

[43]  W. Weiner,et al.  Impact of psychogenic movement disorders versus Parkinson's on disability, quality of life, and psychopathology , 2007, Movement disorders : official journal of the Movement Disorder Society.

[44]  G. Bhanot,et al.  Analysis of breast cancer progression using principal component analysis and clustering , 2007, Journal of Biosciences.

[45]  R. Baron,et al.  painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain , 2006, Current medical research and opinion.

[46]  A. Barsky,et al.  A systematic review of the epidemiology of somatisation disorder and hypochondriasis. , 2004, Journal of psychosomatic research.

[47]  Rohit Bakshi,et al.  Fatigue associated with multiple sclerosis: diagnosis, impact and management , 2003, Multiple sclerosis.

[48]  P. Rothwell,et al.  The 12 year prognosis of unilateral functional weakness and sensory disturbance , 2003, Journal of neurology, neurosurgery, and psychiatry.

[49]  D. D. de Ridder,et al.  Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression. , 2002, Journal of psychosomatic research.

[50]  Alicia A. Grandey,et al.  Relationship Between Coping, Cognitive Dysfunction and Depression in Multiple Sclerosis , 2002, The Clinical neuropsychologist.

[51]  A. Lang,et al.  Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. , 2001, Neuropsychiatry, neuropsychology, and behavioral neurology.

[52]  Nigel V. Marsh,et al.  Neuropsychological Aspects of Multiple Sclerosis , 1998, Neuropsychology Review.

[53]  G. Bleijenberg,et al.  The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. , 1996, Archives of neurology.

[54]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[55]  P. Bartel,et al.  Neuropsychological test performance and affect in myasthenia gravis , 1995, Acta neurologica Scandinavica.

[56]  G. Schüssler,et al.  Coping with myasthenia gravis and implications for psychotherapy. , 1993, Archives of neurology.

[57]  N. Larocca,et al.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.

[58]  Lauren B. Krupp,et al.  Fatigue in multiple sclerosis. , 1988, Archives of neurology.

[59]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[60]  B. Garcin,et al.  Quality of life in functional movement disorders is as altered as in organic movement disorders. , 2019, Journal of psychosomatic research.

[61]  Janet Callahan,et al.  Outpatient Physical Therapy for Functional Neurological Disorder: A Preliminary Feasibility and Naturalistic Outcome Study in a U.S. Cohort. , 2019, The Journal of neuropsychiatry and clinical neurosciences.

[62]  J. Hort,et al.  Subjective Cognitive Complaints in Cognitively Healthy Older Adults and Their Relationship to Cognitive Performance and Depressive Symptoms. , 2017, Journal of Alzheimer's disease : JAD.

[63]  G. Nielsen Physical treatment of functional neurologic disorders. , 2016, Handbook of clinical neurology.

[64]  C. Gudex,et al.  From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[65]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[66]  C. Warlow,et al.  Which neurological diseases are most likely to be associated with “symptoms unexplained by organic disease” , 2011, Journal of Neurology.

[67]  R. Tibshirani,et al.  Estimating the number of clusters in a data set via the gap statistic , 2000 .

[68]  C. Tennant,et al.  Psychological correlates of myasthenia gravis: a brief report. , 1986, Journal of psychosomatic research.

[69]  E. Pinter [The prognosis]. , 1982, Krankenpflege Journal.